Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.9800
0.00 (0.00%)
Jun 18, 2026, 10:02 AM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 707.37 million as of June 17, 2026. Its market cap has decreased by -44.75% in one year.
Market Cap
707.37M
Enterprise Value
-1.50B
Revenue
39.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 707.37M, a decrease of -95.64%. That is a compound annual growth rate of -46.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 707.37M | -30.44% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | 16.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.16B |
| Cloudbreak Pharma | 996.59M |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 814.17M |
| 3D Medicines | 723.01M |
| JW (Cayman) Therapeutics Co. | 669.73M |
| Shanghai Bio-heart Biological Technology | 657.23M |
| Transcenta Holding | 597.30M |